miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis

Area of Science:

• Molecular Biology
• Cell Biology
• Vascular Biology

Background:

• Endothelial cell death contributes to vascular diseases like atherosclerosis and ischemia.
• The miR-17-92 cluster is crucial for angiogenesis and tissue development but its role in endothelial ferroptosis is unknown.
• Ferroptosis, a regulated form of cell death, is implicated in various pathological conditions.

Purpose of the Study:

• To investigate the role of the miR-17-92 cluster in regulating endothelial cell ferroptosis.
• To identify novel regulators and mechanisms involved in erastin-induced endothelial ferroptosis.
• To elucidate the molecular axis through which miR-17-92 exerts its protective effects.

Main Methods:

• Overexpression and knockdown of miR-17-92 and A20 in human umbilical vein endothelial cells (HUVECs).
• Assessment of cell viability, reactive oxygen species (ROS) generation, and ferroptosis markers (GPX4, ACSL4).
• Western blotting, immunoprecipitation, and lentivirus-mediated gene transfer techniques were employed.

Main Results:

• miR-17-92 overexpression protected HUVECs from erastin-induced ferroptosis, reducing growth inhibition and ROS.
• A20, a target of miR-17-92, was identified as a novel regulator of endothelial ferroptosis.
• The A20-ACSL4 axis was found to be critical in erastin-induced ferroptosis, with miR-17-92 targeting this axis.

Conclusions:

• miR-17-92 plays a protective role against erastin-induced ferroptosis in endothelial cells.
• The study identifies a novel mechanism involving the A20-ACSL4 axis in endothelial ferroptosis regulation.
• Targeting the miR-17-92/A20/ACSL4 pathway may offer therapeutic strategies for vascular diseases.